Catalyst Wire Dossier Catalyst Wire Dossier

Sanchitongtshu Plus

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sanchitongtshu Plus, covering 2016-11-29 to 2016-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study [NA]

See pricing